ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Research on the biological mechanism and potential application of CEMIP

Article in Frontiers in Immunology (August 2023)

TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway

Article in Nature Communications (May 2023)

Curcumol inhibits breast cancer growth via NCL/ERα36 and the PI3K/AKT pathway

Article in Food & Function (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.